Recent Changes in Risk Factors of Chronic Subdural Hematoma

Objective Chronic subdural hematoma (CSDH) is a typical disease that is encountered frequently in neurosurgical practice. The medications which could cause coagulopathies were known as one of the risk factors of CSDH, such as anticoagulants (ACs) and antiplatelet agents (APs). Recently, the number of patients who are treated with ACs/APs is increasing, especially in the elderly population. With widespread use of these drugs, there is a need to study the changes in risk factors of CSDH patients. Methods We retrospectively reviewed 290 CSDH patients who underwent surgery at our institute between 1996 and 2010. We classified them into three groups according to the time of presentation (Group A : the remote period group, 1996-2000, Group B : the past period group, 2001-2005, and Group C : the recent period group, 2006-2010). Also, we performed the comparative analysis of independent risk factors between three groups. Results Among the 290 patients, Group A included 71 patients (24.5%), Group B included 98 patients (33.8%) and Group C included 121 patients (41.7%). Three patients (4.2%) in Group A had a history of receiving ACs/APs, 8 patients (8.2%) in Group B, and 19 patients (15.7%) in Group C. Other factors such as head trauma, alcoholism, epilepsy, previous neurosurgery and underlying disease having bleeding tendency were also evaluated. In ACs/APs related cause of CSDH in Group C, significantly less proportion of the patients are associated with trauma or alcohol compared to the non-medication group. Conclusion In this study, the authors concluded that ACs/APs have more importance as a risk factor of CSDH in the recent period compared to the past. Therefore, doctors should prescribe these medications carefully balancing the potential risk and benefit.

[1]  V. Seifert,et al.  The influence of preoperative anticoagulation on outcome and quality of life after surgical treatment of chronic subdural hematoma , 2010, Journal of Clinical Neuroscience.

[2]  L. Koskinen,et al.  Anticoagulants and antiplatelet agents and the risk of development and recurrence of chronic subdural haematomas , 2009, Journal of Clinical Neuroscience.

[3]  Chang Hyun Kim,et al.  Chronic subdural hematomas : a comparative study of three types of operative procedures. , 2009, Journal of Korean Neurosurgical Society.

[4]  Kazumichi Yoshida,et al.  INDEPENDENT PREDICTORS FOR RECURRENCE OF CHRONIC SUBDURAL HEMATOMA: A REVIEW OF 343 CONSECUTIVE SURGICAL CASES , 2008, Neurosurgery.

[5]  J. Suarez,et al.  Coagulopathy and inhospital deaths in patients with acute subdural hematoma. , 2008, Journal of neurosurgery.

[6]  Jae-Hyoo Kim,et al.  Clinical analysis of risk factors related to recurrent chronic subdural hematoma. , 2008, Journal of Korean Neurosurgical Society.

[7]  H. Kwon,et al.  Factors Influencing Recurrent Chronic Subdural Hematoma after Surgery. , 2007 .

[8]  Sang Keun Park,et al.  Clinical Analysis of Recurrent Chronic Subdural Hematoma. , 2006 .

[9]  P. Gorelick,et al.  Risk of Hemorrhagic Stroke With Aspirin Use: An Update , 2005, Stroke.

[10]  O. Gratzl,et al.  Demographics and prevalent risk factors of chronic subdural haematoma: results of a large single-center cohort study , 2004, Neurosurgical Review.

[11]  J. Youm,et al.  Postoperative Radiological Changes in Chronic Subdural Hematoma and Its Relation to Recurrence. , 2004 .

[12]  S. Agus,et al.  Low-dose aspirin prophylaxis and risk of intracranial hemorrhage in patients older than 60 years of age with mild or moderate head injury: a prospective study. , 2003, Journal of neurosurgery.

[13]  M. Lawton,et al.  Spontaneous intracerebral hemorrhage due to coagulation disorders. , 2003, Neurosurgical focus.

[14]  Kyu Hong Kim,et al.  Prognostic Factors of Chronic Subdural Hematoma , 2002 .

[15]  A Majeed,et al.  Trends in the prevalence and management of atrial fibrillation in general practice in England and Wales, 1994–1998: analysis of data from the general practice research database , 2001, Heart.

[16]  N. Buxton,et al.  Warfarin and chronic subdural haematomas , 2001, British journal of neurosurgery.

[17]  M. Levy,et al.  Causes, epidemiology, and risk factors of chronic subdural hematoma. , 2000, Neurosurgery clinics of North America.

[18]  F. Fazekas,et al.  Magnetic resonance imaging of cerebral microbleeds. , 2000, Current opinion in neurology.

[19]  Kim Ts,et al.  A Clinical Analysis of Chronic Subdural Hematoma according to Age Factor. , 2000 .

[20]  S. Chibbaro,et al.  Management of chronic subdural hematoma in patients treated with anticoagulation. , 1999, Journal of neurosurgical sciences.

[21]  David C. Anderson,et al.  Bleeding during antithrombotic therapy in patients with atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators. , 1996, Archives of internal medicine.

[22]  R. Hart,et al.  Oral anticoagulants and intracranial hemorrhage. Facts and hypotheses. , 1995, Stroke.

[23]  H. Mattle,et al.  Anticoagulation-related intracranial extracerebral haemorrhage. , 1989, Journal of neurology, neurosurgery, and psychiatry.

[24]  B. Weir,et al.  Factors affecting coagulation: fibrinolysis in chronic subdural fluid collections. , 1983, Journal of neurosurgery.

[25]  J. Tijssen,et al.  Subdural hematoma and oral anticoagulant therapy. , 1982, Archives of neurology.

[26]  T. Markwalder Chronic subdural hematomas: a review. , 1981, Journal of neurosurgery.